Roy Clifford Levitt

Dr. Levitt has >35 years of experience as a physician-scientist and in pharmaceuticals development including leadership in the development stage and global commercial biopharmaceuticals. He is a serial inventor with >25 issued patents and an entrepreneur having created and/or led multiple biopharmaceutical companies. Dr. Levitt is the founder of Onspira Therapeutics where he served as CSO and board member that was sold to Sumitomo in 2019. His experience also includes Director Medical Affairs, Commercial Operations, CSL Behring; Chief Executive Officer, President, and board member of Genera Corporation (NASDAQ). He has served as Principal Investigator for multiple competitive Awards including the DoD, NIH, Cystic Fibrosis and Coulter Foundations.